Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Clinical trial NCT02623920 · WITHDRAWN

Trial details

NCT number: NCT02623920
Sponsor: University of Arizona
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Mediastinal Large B-cell Lymphoma Grey Zone Lymphoma High Grade B Cell Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Small Lymphocytic Lymphoma

Start date: 2015-12-16
Primary completion: 2017-05-17
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.